The Prescription Drug Sales Division manages sales activities for ethical pharmaceuticals, with specialization in three targeted areas: oncology, allergy/immunology, and urology. Research and development of anticancer agents began more than 35 years ago, and TAIHO PHARMACEUTICAL is now a leading company in this area, with a nearly 80% share of the domestic market for its current oral fluoropyrimidine drugs. Its medical representatives with advanced specialist knowledge support physicians in health care settings by providing them timely with high-quality information tailored to each patient.
|